查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1999343

全球括約肌成形術市場：2026-2032年市場預測（依產品類型、手術方法、年齡層、性別、通路和最終用戶分類）

Surgical Sphincteroplasty Market by Product Type, Technique, Age Group, Gender, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，外科括約肌成形術市場價值將達到 17 億美元，到 2026 年將成長至 17.8 億美元，複合年成長率為 9.59%，到 2032 年將達到 32.3 億美元。

主要市場統計數據
基準年 2025 17億美元
預計年份：2026年 17.8億美元
預測年份 2032 32.3億美元
複合年成長率 (%) 9.59%

對外科括約肌成形術進行簡要概述，重點關注不斷發展的材料、手術路徑以及臨床醫生和採購經理之間的通用優先事項。

括約肌成形術在泌尿系統重組和結直腸外科的交叉領域佔據著至關重要的地位，它透過靶向解剖修復來解決括約肌功能障礙。縫合技術、移植材料和手術方法的進步拓展了臨床選擇，也使得實證材料和手術方案的選擇更加重要。目前，醫療專業人員在選擇可吸收和不可吸收材料時，會考慮其生物相容性、抗張性能和長期組織整合情況，而患者的合併症、年齡和手術史在決定手術方案方面也日益重要。

材料創新、外科技術改進和醫療保健服務的進步如何重塑括約肌成形術的臨床選擇和商業性定位。

外科括約肌成形術領域正經歷一場變革，其驅動力來自於材料創新、手術技術改進以及醫療服務模式的轉變。新型可吸收和不可吸收縫合線配方以及生物基和合成移植物的應用，改變了術中選擇和術後結果，迫使外科醫生在即時機械修復與長期組織反應之間尋求平衡。同時，從即時一期修復策略到延遲二次手術以及各種疊加結構，手術技術的進步正在拓展臨床醫生可選擇的手術方案。

2025 年美國關稅調整對括約肌重建手術器械的供應鏈、籌資策略和臨床可用性的綜合影響。

關稅政策和貿易措施的變化會對整個外科手術供應鏈產生連鎖反應，影響括約肌成形術相關產品的成本、籌資策略和分銷模式。 2025年，主要市場關稅和進口稅的調整迫使製造商和經銷商重新評估製造地和物流策略。同時，醫療採購團隊也重新審視了與供應商的關係，以維持成本穩定和臨床服務的連續性。這些趨勢使得採購管道多元化以及對到貨成本（除表面價格外）的更深入了解變得更加重要。

細分市場層面的洞察揭示了產品類型、手術技術、最終用戶特徵、分銷管道和患者人口統計特徵如何決定策略重點。

細分市場趨勢揭示了不同的需求促進因素，這些因素指南產品開發、臨床應用和分銷策略。按產品類型分類，該市場包括可吸收縫線、植入材料和網片解決方案（包括氧環己酮聚合體和聚乙醇酸衍生物），以及尼龍和聚丙烯等不可吸收縫線。每種材料類別都有其獨特的操作特性、組織反應特徵和外科醫生偏好，這些因素反過來又會影響培訓需求和庫存計劃。當組織重塑是首要考慮因素時，可吸收材料往往是首選；而當需要長期張力支撐時，不可吸收材料仍然是首選。

區域趨勢和醫療保健系統特徵決定了全球市場的監管策略、臨床引入模式和分銷重點。

區域趨勢差異顯著，進而影響研究重點、監理路徑和商業化策略。在美洲，成熟的臨床卓越中心和完善的採購體系創造了競爭環境，實證差異化和服務模式決定了醫療資源的取得和推廣。醫保報銷機制和區域專科中心集中了需求，而本地生產和經銷夥伴則影響著供應的可靠性。

重新定義括約肌成形術的製造商策略、臨床夥伴關係與價值主導差異化：競爭與合作的力量

外科括約肌成形術領域的競爭格局由成熟的醫療設備製造商、新興的專業公司以及致力於累積實證醫學證據和改進技術的臨床聯盟共同構成。大型成熟企業憑藉其廣泛的分銷網路和整合的臨床培訓項目，在醫院和門診管道保持著穩固的地位。另一方面，專業製造商則透過材料科學的創新和針對特定手術的客製化解決方案來脫穎而出。Start-Ups和利基創新者通常專注於新型移植物配方和縫合技術，旨在解決特定的失效模式或簡化手術流程。

為製造商、臨床領導者和採購團隊制定的切實可行的行動計劃，旨在協調證據計劃、供應彈性和通路策略，以實現永續成長。

產業領導者應著重採取一系列切實可行的措施，使商業策略與臨床實際情況和供應鏈韌性相契合。優先投資於強力的臨床證據項目，以比較不同材料類型和手術方式的治療效果，並增強外科醫生採用新材料所需的信心。同時，透過供應商多元化、協商靈活的合約機制以及探索區域性製造和組裝來最佳化供應鏈，從而保護企業免受貿易中斷的影響。

我們透明、多方面的調查方法，結合了對臨床醫生的訪談、監管審查和供應鏈分析，支持可操作的見解和可重複的研究結果。

本研究整合了來自同行評審臨床文獻、相關人員訪談、監管文件和供應鏈分析的交叉檢驗訊息，以確保其具有全面且檢驗的基礎。主要研究包括與執業外科醫生、採購經理和分銷合作夥伴進行結構化討論，以收集有關器械操作、庫存流動和醫療保健優先事項的第一手資訊。二級資訊來源包括臨床試驗庫、器械註冊庫和公開的監管文件，以支援臨床性能和器械分類。

對決定括約肌成形術實施的成功和永續價值的臨床、商業性和價值鏈因素進行前瞻性整合。

括約肌成形術正處於材料科學、外科技術創新和不斷變化的醫療服務模式的交匯點，這既帶來了臨床機遇，也帶來了商業性的挑戰。將嚴謹的臨床證據與靈活的供應和分銷策略相結合的相關人員，將更有能力滿足臨床醫生的期望和醫療採購需求。外科技術的進步和門診環境的擴展凸顯了對操作可預測、療效可靠且可擴展分銷的醫療設備的需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 外科括約肌成形術市場：依產品類型分類

  • 可吸收縫線
    • 氧環己酮聚合體
    • 聚乙醇酸
  • 接枝
  • 網
  • 不可吸收縫線
    • 尼龍
    • 聚丙烯

第9章 外科括約肌成形術市場：依技術分類

  • 延遲二次法
  • 即時原發性手術
  • 重疊法
    • 從頭到尾
    • 左右

第10章 外科括約肌成形術市場：依年齡層別分類

  • 成人版
  • 老年人
  • 兒童

第11章 外科括約肌成形術市場：性別

  • 女士
  • 男性

第12章 外科括約肌成形術市場：依通路分類

  • 直銷
    • 銷售代理
    • 製造商
  • 醫院採購
  • 線上
    • B2B電子商務
    • B2C

第13章 外科括約肌成形術市場：依最終使用者分類

  • 門診手術中心
    • 獨立的
    • 醫院附屬機構
  • 醫院和診所
    • 私人的
    • 民眾

第14章 外科括約肌成形術市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 外科括約肌成形術市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 外科括約肌成形術市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 美國外科括約肌成形術市場

第18章 中國外科括約肌成形術市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Coloplast A/S
  • ConMed Corporation
  • Cook Medical LLC
  • Hologic, Inc.
  • Integra LifeSciences Holdings Corporation
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Novo Surgical, Inc.
  • Olympus Corporation
  • Smith & Nephew PLC
  • Stryker Corporation
  • Teleflex Incorporated
  • The Cooper Companies, Inc.
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-3A2E844FE1EC

The Surgical Sphincteroplasty Market was valued at USD 1.70 billion in 2025 and is projected to grow to USD 1.78 billion in 2026, with a CAGR of 9.59%, reaching USD 3.23 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.70 billion
Estimated Year [2026] USD 1.78 billion
Forecast Year [2032] USD 3.23 billion
CAGR (%) 9.59%

A concise orientation to surgical sphincteroplasty emphasizing evolving materials, surgical pathways, and the converging priorities of clinicians and procurement leaders

Surgical sphincteroplasty occupies a pivotal position at the intersection of reconstructive urology and colorectal surgery, addressing sphincter dysfunction through targeted anatomical repair. Advances in suture technology, graft materials, and operative techniques have expanded clinical options and raised the importance of evidence-based selection of materials and approaches. Practitioners now weigh biocompatibility, tensile properties, and long-term integration when choosing between absorbable and nonabsorbable materials, while procedural decision-making increasingly incorporates patient comorbidity, age, and prior surgical history.

As the clinical community integrates minimally invasive adjuncts and refines perioperative protocols, the role of ambulatory surgical centers alongside traditional hospital settings has grown. This shift underscores the need for surgeons, procurement professionals, and product developers to align around cost-effective care pathways, predictable outcomes, and streamlined supply chains. Consequently, a nuanced understanding of product attributes, technique-specific outcomes, and end-user logistics is essential for stakeholders seeking to optimize clinical efficacy and commercial performance in this specialized surgical domain.

How innovations in materials, procedural refinements, and care delivery evolution are reshaping clinical choices and commercial positioning in sphincteroplasty

The landscape of surgical sphincteroplasty is experiencing transformative shifts driven by material innovation, procedural refinement, and changing care delivery models. Novel absorbable and nonabsorbable suture formulations alongside biologic and synthetic grafts have altered intraoperative choices and postoperative expectations, prompting surgeons to balance immediate mechanical repair with long-term tissue response. Concurrently, refinements in surgical technique-ranging from immediate primary repair strategies to delayed secondary interventions and various overlapping configurations-have broadened the procedural toolkit available to clinicians.

In parallel, the growth of ambulatory surgical centers and the increasing sophistication of hospital procurement practices have recalibrated distribution and purchasing dynamics. These care-delivery transformations elevate the importance of device ease-of-use, inventory predictability, and total procedure cost. Moreover, heightened regulatory scrutiny and an emphasis on value-based outcomes are compelling manufacturers and clinical teams to substantiate product performance through rigorous evidence generation and post-market surveillance, thereby reshaping how new technologies enter and scale within clinical practice.

The compound implications of United States tariff adjustments in 2025 on supply chains, procurement strategies, and clinical availability for sphincteroplasty devices

Tariff policy changes and trade measures can create ripple effects across surgical supply chains, influencing costs, sourcing strategies, and distribution models for sphincteroplasty-related products. In 2025, adjustments to tariffs and import duties in key markets prompted manufacturers and distributors to reassess manufacturing footprints and logistics strategies, while procurement teams in healthcare institutions revisited supplier relationships to preserve cost stability and clinical continuity. These developments reinforced the need for diversified sourcing and clearer visibility into landed costs beyond headline prices.

Consequently, many organizations intensified efforts to localize components, negotiate fixed-price agreements, and leverage centralized procurement vehicles to mitigate exposure to tariff volatility. For clinical stakeholders, these commercial shifts translated into evolving product availability patterns and a renewed emphasis on product equivalence assessments. Looking ahead, resilience in the supply chain will increasingly hinge on flexible manufacturing strategies, expanded regional supplier bases, and collaborative contracting approaches that minimize disruption while supporting consistent patient care.

Segment-level insights revealing how product types, surgical techniques, end-user characteristics, distribution channels, and patient demographics direct strategic priorities

Segment-level dynamics reveal differentiated demand drivers that inform product development, clinical adoption, and distribution strategies. Based on product type, the landscape encompasses absorbable sutures, including polydioxanone and polyglycolic acid variants, graft materials, mesh solutions, and nonabsorbable sutures such as nylon and polypropylene. Each material class presents distinct handling characteristics, tissue response profiles, and surgeon preferences, which in turn influence training requirements and inventory planning. Absorbable alternatives often appeal where tissue remodeling is prioritized, whereas nonabsorbable options retain favor in scenarios demanding long-term tensile support.

Technique-based segmentation shows meaningful implications for device design and clinical training, with delayed secondary approaches, immediate primary repairs, and overlapping techniques-further delineated into end-to-end and side-to-side configurations-demanding specific instrument ergonomics and suture performance. End users shape procurement cadence and product configuration needs, as ambulatory surgical centers, whether freestanding or hospital-affiliated, prioritize streamlined kits and rapid turnover while hospitals, both private and public, emphasize broad product portfolios and contract compliance. Distribution channels likewise affect market access and service models: direct sales through distributors or manufacturers, hospital procurement via direct purchases or group purchasing organizations, and online avenues spanning B2B ecommerce and B2C platforms each require tailored commercial strategies. Patient demographics add another layer of granularity, with adult, geriatric, and pediatric populations presenting differing anatomical and healing characteristics, and gender considerations between female and male patients influencing clinical decision-making and outcome measurement. Taken together, these segmentation perspectives should guide targeted clinical evidence generation, differentiated product positioning, and channel-specific commercial planning.

Regional dynamics and healthcare system nuances that determine regulatory strategy, clinical adoption patterns, and distribution priorities across global markets

Regional dynamics vary substantially and shape research priorities, regulatory pathways, and commercialization tactics. In the Americas, established centers of clinical excellence and mature procurement frameworks create a competitive environment where evidence-based differentiation and service models determine access and uptake. Reimbursement structures and regional centers of expertise concentrate demand, while localized manufacturing and distribution partnerships influence supply reliability.

Across Europe, Middle East & Africa, heterogeneous regulatory regimes and variable healthcare funding mechanisms necessitate adaptive market entry strategies that account for national-level tenders, clinical adoption cycles, and differing hospital capabilities. Strategic partnerships and region-specific clinical data often accelerate acceptance in diverse health systems. In the Asia-Pacific, rapid expansion of surgical capacity, investments in ambulatory surgical infrastructure, and a growing emphasis on minimally disruptive care pathways are driving demand for versatile, cost-effective solutions. Local manufacturing initiatives and regional regulatory harmonization efforts further affect product availability and competitive dynamics. Together, these regional patterns underscore the importance of tailoring clinical evidence, pricing, and distribution to local system characteristics to achieve sustainable adoption.

Competitive and collaborative forces redefining manufacturer strategies, clinical partnerships, and value-driven differentiation in sphincteroplasty

Competitive landscapes in surgical sphincteroplasty are shaped by a mix of legacy medical device firms, emerging specialized manufacturers, and clinical consortia focused on evidence development and technique refinement. Established players leverage deep distribution networks and integrated clinical training programs to maintain visibility in hospital and ambulatory channels, while specialized manufacturers differentiate through material science innovations and targeted procedural solutions. Start-ups and niche innovators often focus on novel graft formulations or suture technologies designed to address specific failure modes or to simplify operative workflow.

Collaborations between clinical centers and commercial partners have become more frequent, producing real-world evidence and procedural refinements that accelerate adoption. At the same time, strategic partnerships with distributors, group purchasing organizations, and ecommerce platforms expand market reach but require alignment on service levels and value-based contracting. For market entrants and incumbents alike, sustained competitive advantage is increasingly tied to demonstrable clinical outcomes, robust post-market surveillance, and the ability to integrate educational support into the customer value proposition.

Practical action plans for manufacturers, clinical leaders, and procurement teams to align evidence programs, supply resilience, and channel strategies for sustainable growth

Industry leaders should focus on a set of pragmatic actions that align commercial strategy with clinical realities and supply chain resilience. Prioritize investment in robust clinical evidence programs that compare material classes and technique-specific outcomes to give surgeons the confidence needed for adoption. In parallel, optimize supply arrangements by diversifying supplier bases, negotiating flexible contracting mechanisms, and exploring regional manufacturing or assembly to insulate against trade-related disruptions.

Commercial teams ought to tailor channel strategies to end-user needs: develop streamlined procedural kits and rapid-replenishment models for ambulatory surgical centers while offering comprehensive portfolio and compliance solutions for hospital systems. Embrace digital channels for customer engagement and product education, and ensure that ecommerce and direct-sales models integrate with hospital procurement processes. Finally, invest in post-market surveillance and clinician-facing training to demonstrate long-term value, reduce adverse outcomes, and foster clinical champions who can validate product performance in real-world settings.

A transparent, multi-source research methodology combining clinician interviews, regulatory review, and supply chain analysis to underpin actionable insights and reproducible findings

This research synthesizes triangulated inputs from peer-reviewed clinical literature, stakeholder interviews, regulatory documentation, and supply chain analyses to ensure a comprehensive and verifiable foundation. Primary research included structured discussions with practicing surgeons, procurement leads, and distribution partners to capture experiential insights on device handling, inventory flows, and institutional priorities. Secondary sources comprised clinical trial repositories, device registries, and publicly available regulatory filings to corroborate clinical performance and device classifications.

Analytical methods integrated qualitative coding of interview data with thematic trend analysis to identify recurring drivers of adoption and barriers to scale. Supply chain assessments applied scenario modeling to evaluate procurement sensitivity to tariff shifts, while competitive mapping examined product portfolios, channel footprints, and collaboration patterns. Throughout, emphasis was placed on transparency of assumptions and traceability of sources, and readers are directed to the methodology appendices for detailed interview counts, search protocols, and document inventories that support reproducibility and validation of the findings.

A forward-looking synthesis of clinical, commercial, and supply chain factors that will determine successful adoption and sustained value in sphincteroplasty

Surgical sphincteroplasty is evolving at the confluence of material science, surgical technique innovation, and shifting care delivery models, presenting both clinical opportunities and commercial complexity. Stakeholders who integrate rigorous clinical evidence with adaptive supply and channel strategies will be best positioned to meet clinician expectations and institutional procurement needs. The year-on-year procedural refinements and growth of ambulatory settings underscore the need for devices that offer predictable handling, robust outcomes, and scalable distribution.

As regulatory environments and trade policies continue to influence product movement and pricing, resilience through diversified sourcing and validated clinical performance will become central to sustainable adoption. Ultimately, the future of sphincteroplasty will favor those who can demonstrate clear patient benefits, support clinicians with practical training and evidence, and align commercial operations to the nuanced requirements of hospitals, ambulatory centers, and digital procurement channels.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Sphincteroplasty Market, by Product Type

  • 8.1. Absorbable Sutures
    • 8.1.1. Polydioxanone
    • 8.1.2. Polyglycolic Acid
  • 8.2. Graft
  • 8.3. Mesh
  • 8.4. Nonabsorbable Sutures
    • 8.4.1. Nylon
    • 8.4.2. Polypropylene

9. Surgical Sphincteroplasty Market, by Technique

  • 9.1. Delayed Secondary Technique
  • 9.2. Immediate Primary Technique
  • 9.3. Overlapping Technique
    • 9.3.1. End-To-End
    • 9.3.2. Side-To-Side

10. Surgical Sphincteroplasty Market, by Age Group

  • 10.1. Adult
  • 10.2. Geriatric
  • 10.3. Pediatric

11. Surgical Sphincteroplasty Market, by Gender

  • 11.1. Female
  • 11.2. Male

12. Surgical Sphincteroplasty Market, by Distribution Channel

  • 12.1. Direct Sales
    • 12.1.1. Distributor
    • 12.1.2. Manufacturer
  • 12.2. Hospital Procurement
  • 12.3. Online
    • 12.3.1. B2B Ecommerce
    • 12.3.2. B2C

13. Surgical Sphincteroplasty Market, by End User

  • 13.1. Ambulatory Surgical Centers
    • 13.1.1. Freestanding
    • 13.1.2. Hospital-Affiliated
  • 13.2. Hospitals & Clinics
    • 13.2.1. Private
    • 13.2.2. Public

14. Surgical Sphincteroplasty Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Surgical Sphincteroplasty Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Surgical Sphincteroplasty Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Surgical Sphincteroplasty Market

18. China Surgical Sphincteroplasty Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. B. Braun Melsungen AG
  • 19.7. Baxter International Inc.
  • 19.8. Becton Dickinson and Company
  • 19.9. Boston Scientific Corporation
  • 19.10. Coloplast A/S
  • 19.11. ConMed Corporation
  • 19.12. Cook Medical LLC
  • 19.13. Hologic, Inc.
  • 19.14. Integra LifeSciences Holdings Corporation
  • 19.15. Intuitive Surgical, Inc.
  • 19.16. Johnson & Johnson
  • 19.17. Medtronic plc
  • 19.18. Merit Medical Systems, Inc.
  • 19.19. Novo Surgical, Inc.
  • 19.20. Olympus Corporation
  • 19.21. Smith & Nephew PLC
  • 19.22. Stryker Corporation
  • 19.23. Teleflex Incorporated
  • 19.24. The Cooper Companies, Inc.
  • 19.25. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA SURGICAL SPHINCTEROPLASTY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY POLYDIOXANONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY POLYDIOXANONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY POLYDIOXANONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NYLON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NYLON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NYLON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DELAYED SECONDARY TECHNIQUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DELAYED SECONDARY TECHNIQUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DELAYED SECONDARY TECHNIQUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY IMMEDIATE PRIMARY TECHNIQUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY IMMEDIATE PRIMARY TECHNIQUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY IMMEDIATE PRIMARY TECHNIQUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END-TO-END, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END-TO-END, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END-TO-END, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SIDE-TO-SIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SIDE-TO-SIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SIDE-TO-SIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY FEMALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY FEMALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY FEMALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY MALE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY MALE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY MALE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY MANUFACTURER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY MANUFACTURER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY MANUFACTURER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITAL PROCUREMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITAL PROCUREMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITAL PROCUREMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY B2B ECOMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY B2B ECOMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY B2B ECOMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY B2C, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY B2C, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY B2C, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY FREESTANDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY FREESTANDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY FREESTANDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITAL-AFFILIATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITAL-AFFILIATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITAL-AFFILIATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 236. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 239. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 240. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 241. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 242. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 243. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 244. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 245. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 246. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 247. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 249. GCC SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 278. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 279. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 281. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 282. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 283. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 284. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 285. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 286. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 287. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 288. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 289. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 290. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 291. G7 SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 292. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 293. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 295. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 296. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 297. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 298. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 299. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY GENDER, 2018-2032 (USD MILLION)
  • TABLE 300. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 301. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 302. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 303. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 304. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 305. NATO SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 306. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY ABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY NONABSORBABLE SUTURES, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED STATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY OVERLAPPING TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES SURGICAL SPHINCTEROPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES SURGICAL SPHINC